Member Info for CHELSEA7

Morning All, had a second listen to Cliff Holloways presentation (now 80 views) this morning and the pipelines themselves speak volumes for a "small Biotech"" and what has and is being developed on a relatively small budget.

He made reference to 18 months for meaningful data presumably for our three lead candidates in trial, and constant refences to unmet clinical needs, presumbly that qualifies for costs of KEYTRUDA to be met, and wasn"t sure that was extended to European trials, hence making it easier for us to find more sites in the U.K........anyone know?

His confidence over Avidamab comes over quite clearly, and we are six months into the first collaboration already, so all three collaborations, so far, could produce commercial deals in 2020., as I guess originally planned.

My perception of Chris Holloway has changed enormously in the last year, for the better, and I am sure Richard Goodfellow has been very supportive of him, he is just now speaking with an aura of self confidence which he has grown into.

Thanks as ever to cc for supplying the link, re-posyed now for ease............https://m.youtube.com/watch?v=TgJXxf3a66M

It is only 16 minutes short, give it a listen and Lochinager Lass that will be the most updated review we all have for reference..

A strange day of tiny trades yesterday, 11 trades, totalling just 50k volume, 45k of which were sells, and ending the day unchanged at 7.15p. Lets have a blue day today, some six figure buys, and a Good news RNS to propel us through 8.

BTW, 69 VIEWS now since Wildforce posted 24. Nice interest from shareholders so soon, I would expect that to exceed 200 views very soon.

GN All

Another very good presentation from Chris, keeps growing in confidence, and I just like him.

Knowlesi I find that very encouraging, whilst the core platforms get closer to clinical trials. We seem to have a commercial winner here, which will only assist the core platforms and we know pretty much the plans for them now.

Buys 5k

Sells 45k

11 Trades, hmm

GN

keeptofacts, well you have to get to Liverpool Street first. Why is that an issue??

Hi scooby, well the administrators, if appointed, would just serve notice on existing members of staff anyway.

There is always a Plan B??? I wonder what that might be.

Very good post.

That should now be the focus, to get the FCA to investigate the conduct of the Directors, there is enough in those RNSs IMHO to bring charges against them all.

7/7.30, after a 17k sell at 7p

Well done to you Freddie.

I wonder whether we will now see the likes of Valiseek or another phoenix company rise from the ashes??

I find it incomprehensible that George was not their at the meeting, he knew the result beforehand, which should quell any argument that you Freddieboy was not talking for the majority of holders. Well done, hope you got a few beers for a long journey home. Respect.

Sorry "bout that, Chris Holloway and Lindy Durrant speaking on behalf of Scancell on You Tube, and I would have thought on the Scancell Website too.

Afraid I don"t LL, but you will find a few videos of Robin Goodfellow,

Make that 9 trades, volume 33k and pretty odd last couple of trades................

Time Trade Price Volume
10:36:13 7.02 405 28.43
10:36:10 7.02 300 21.06
10:10:07 7.02 249 17.48

""300""" Track the share sideways, I thought they were!!!

A quiet morning here, and freezing cold at that, seven trades here, a volume of 32k of which 27k are sells.

Hope you had a good weekend..

Seems to me the lay out of Vulpes in real terms was a lot higher than one could get from L & G.

Well that s see what this week brings us, a fourth collaboration stills close to me. and would like to see a few six figure buys again. Considering the low volumes I think we have been a bit volatile of late, lets see what is to come?

So TF you agree with Knowlesi. Nobody has said Having Vulpes aboard success is guareented, I guess I am just moreconfidant and sure we will get a few key announcements from Vulpes. Does Martin Diggle have many othe r Vulpes Investments to keep them busy, (do you have a link for that.)

Glad you agreed of the original problem write or wrong..............."".Some doubt Scancell's acumen/negotiating but I think we will have to judge that when we have more data 'cards' to play"" And all I am saying that beng the case jusy perhaps we have filled that gap, and believe me if that is the case we will be involved at every juncture. The report from OXF3 VCT had the same level of confidence as I do, and put in a good aricle into the Haly Year Report Sept 2019

Thanks again cc, the events are taking shape again and .Scancell seem to be raising there profile in this Pivotal Year

I couldn"t pick up anything you say, once again it is a case of opinions, I hope mine happens, lol.

I believe they are still shareholders Knowlesi, mind you the difference betweens both sels of research is about four/five years.

Fascinating, so you don"t find the company providing the funding will be kept out of importance decisions?? Realll y can"t see any reason for that